Cradle, founded in 2021 and based in Amsterdam and Zurich, sells software that uses AI to design and optimise proteins for drug, enzyme and other R&D work. It raised a $73 million Series B led by IVP, taking total funding past $100 million.
At a glance
| Price from | Custom |
| Best for | R&D teams engineering proteins in house |
From Cradle's own website.
What stands out
- Software that research teams can license
- Used by large biotech companies
Worth knowing
- Tool provider, not a drug developer
- Smaller than US peers
How it ranks
Cradle is ranked 10th of 10 in Best AI Drug Discovery Startups (Lister Score 85.3).
#10 in Best AI Drug Discovery Startups · Lister Score 85.3
Cradle names Novo Nordisk and Ginkgo Bioworks among its partners..
| Rank | Best AI Drug Discovery Startups | Score |
|---|---|---|
| 1 | Isomorphic Labs | 97.1 |
| 2 | Xaira Therapeutics | 95.8 |
| 3 | Chai Discovery | 94.6 |
| 4 | Enveda | 93.3 |
| 5 | insitro | 92.0 |
| 6 | Formation Bio | 90.7 |
| 7 | Genesis Molecular AI | 89.4 |
| 8 | BigHat Biosciences | 88.1 |
| 9 | Terray Therapeutics | 86.7 |
| 10 | Cradle | 85.3 |
Frequently asked questions
How does Cradle rank on Lister?
Cradle is ranked 10th of 10 in Best AI Drug Discovery Startups (Lister Score 85.3).
Appears in
Add this badge to your site
If you work at Cradle, paste this code into your website to show where it ranks on Lister. The badge links to the ranking and updates within a day when the rank changes.